Werkgroep Cardiologische centra Nederland

BaxDUO ARCTIC (Recruiting)

a Phase III, Randomised, Double-Blind, Active-Controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure
Medicine
Baxdrostat
Population
Primairy prevention cardiovasular disease
Phase
III
Starting year
2023

Director of Study

dr. P.M. van der Zee (Cardioloog)
Harderwijk, St.Jansdal Ziekenhuis